Neogeriatrics is categorized under Internal Medicine Doctors in Massillon, OH and active since 2010.
Neogeriatrics was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Jennifer Spoonemore, Office Manager at the company’s single location by writing to 2823 Aaronwood Avenue Ne, Massillon, Ohio OH 44646 or by phoning (330) 830-8666. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Neogeriatrics |
Contact Person: | Jennifer Spoonemore, Office Manager |
Address: | 2823 Aaronwood Avenue Ne, Massillon, Ohio 44646 |
Phone Number: | (330) 830-8666 |
Website Address: | neogeriatrics.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Neogeriatrics was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Jennifer Spoonemore, Office Manager for inquiries that concern Neogeriatrics by calling the company number (330) 830-8666, as your correspondence is most welcome. Additionally, the physical location of the single location of Neogeriatrics can be found at the coordinates 40.82242,-81.49972 as well as the street address 2823 Aaronwood Avenue Ne in Massillon, Ohio 44646.
For its online presence, you may visit Neogeriatrics’s website at neogeriatrics.com and engage with its social media outlets through on Twitter and on Facebook.